{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:18:02Z","timestamp":1767147482536,"version":"build-2238731810"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ijcha.2018.11.008","type":"journal-article","created":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T01:20:14Z","timestamp":1544232014000},"page":"39-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies"],"prefix":"10.1016","volume":"22","author":[{"given":"Enrico","family":"Cerrato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6751-6437","authenticated-orcid":false,"given":"Matteo","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Bagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Biscaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Luciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Destefanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4164-2758","authenticated-orcid":false,"given":"Giorgio","family":"Quadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Meynet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Gravinese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6388-0111","authenticated-orcid":false,"given":"Alessandra","family":"Chinaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8068-2440","authenticated-orcid":false,"given":"Shaun G.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinando","family":"Varbella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2018.11.008_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrcardio.2015.113","article-title":"Switching P2Y12-receptor inhibitors in patients with coronary artery disease","volume":"13","author":"Rollini","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcha.2018.11.008_bb0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2016.03.006","article-title":"Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: review of the literature and practical considerations","volume":"176","author":"De Luca","year":"2016","journal-title":"Am. Heart J."},{"issue":"20","key":"10.1016\/j.ijcha.2018.11.008_bb0015","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/CIRCULATIONAHA.117.031164","article-title":"International expert consensus on switching platelet P2Y12 receptor-inhibiting therapies","volume":"136","author":"Angiolillo","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2018.11.008_bb0020","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ijcha.2018.11.008_bb0025","author":"Wells"},{"key":"10.1016\/j.ijcha.2018.11.008_bb0030","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11239-014-1139-5","article-title":"Safety and efficacy of in-hospital clopidogrel-to-prasugrel switching in patients with acute coronary syndrome. An analysis from the \u201creal world\u201d","volume":"39","author":"Almendro-Delia","year":"2015","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ijcha.2018.11.008_bb0035","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3109\/09537104.2015.1119815","article-title":"Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry","volume":"27","author":"Biscaglia","year":"2016","journal-title":"Platelets"},{"key":"10.1016\/j.ijcha.2018.11.008_bb0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijcard.2016.11.240","article-title":"Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: insights from the Canadian Observational AntiPlatelet sTudy","volume":"228","author":"Bagai","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcha.2018.11.008_bb0045","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11239-013-1039-0","article-title":"Switching from high-dose clopidogrel to prasugrel in ACS patients undergoing PCI: a single-center experience","volume":"38","author":"De Luca","year":"2014","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ijcha.2018.11.008_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2013.10.010","article-title":"In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prevalence, predictors and short-term outcome","volume":"167","author":"Alexopoulos","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcha.2018.11.008_bb0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jcin.2012.09.012","article-title":"Switching acute coronary syndrome patients from prasugrel to clopidogrel","volume":"6","author":"Kerneis","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcha.2018.11.008_bb0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/joic.12139","article-title":"Switching patients from clopidogrel to prasugrel in acute coronary syndrome: impact of the clopidogrel loading dose on platelet reactivity","volume":"27","author":"Lhermusier","year":"2014","journal-title":"J. Interv. Cardiol."},{"key":"10.1016\/j.ijcha.2018.11.008_bb0065","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.amjcard.2012.11.058","article-title":"Safety of reloading prasugrel in addition to clopidogrel loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"111","author":"Loh","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcha.2018.11.008_bb0070","first-page":"220","article-title":"MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel\u2014the European MULTIPRAC Registry","volume":"4","author":"Clemmensen","year":"2015","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"issue":"4","key":"10.1016\/j.ijcha.2018.11.008_bb0075","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4244\/EIJ-D-17-00092","article-title":"Incidence and outcome of switching of oral platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: the SCOPE registry","volume":"13","author":"De Luca","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcha.2018.11.008_bb0080","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/CIRCINTERVENTIONS.112.000063","volume":"6","author":"Diodati","year":"2013","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcha.2018.11.008_bb0085","series-title":"Switching From Clopidogrel to Prasugrel in ACS Patients Undergoing PCI: A Single-center Experience","author":"Chinaglia","year":"2016"},{"key":"10.1016\/j.ijcha.2018.11.008_bb0090","first-page":"499","article-title":"In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the TRANSLATE-ACS study","volume":"4","author":"Bagai","year":"2015","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"10.1016\/j.ijcha.2018.11.008_bb0095","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jacc.2010.02.072","article-title":"Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study","volume":"56","author":"Angiolillo","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2018.11.008_bb0100","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2018.11.008_bb0105","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2018.11.008_bb0110","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(17)32155-4","article-title":"Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial","volume":"390","author":"Sibbing","year":"2017","journal-title":"Lancet"},{"issue":"41","key":"10.1016\/j.ijcha.2018.11.008_bb0115","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1093\/eurheartj\/ehx175","article-title":"Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study","volume":"38","author":"Cuisset","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2018.11.008_bb0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00228-015-1949-1","article-title":"The impact of switching P2Y12 receptor inhibitor therapy during index hospitalization: a systematic review","volume":"72","author":"Chandrasekhar","year":"2016","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcha.2018.11.008_bb0125","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/FJC.0000000000000359","article-title":"Safety and efficacy of switching from clopidogrel to prasugrel in patients undergoing percutaneous coronary intervention: a study-level meta-analysis from 15 studies","volume":"67","author":"Patti","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcha.2018.11.008_bb0130","first-page":"441","article-title":"Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: the EYESHOT Study","volume":"4","author":"De Luca","year":"2015","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"10.1016\/j.ijcha.2018.11.008_bb0135","first-page":"2017","author":"Valgimigli","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2018.11.008_bb0140","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1093\/eurheartj\/ehx437","article-title":"Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients","volume":"38","author":"D'Ascenzo","year":"2017","journal-title":"Eur. Heart J."}],"updated-by":[{"DOI":"10.1016\/j.ijcha.2020.100676","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000}}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906718301271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906718301271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:07:06Z","timestamp":1762492026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906718301271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":28,"alternative-id":["S2352906718301271"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2018.11.008","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2018.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}